Related Experiment Video
Updated: May 7, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
New behavioural variant FTD criteria and clinical practice
1Université de Lille, Nord-de-France, 1, bis rue Lefèvre, 59000 Lille, France; UDSL EA 1046, hôpital Roger-Salengro, clinique neurologique, CHU de Lille, avenue du Pr-Émile-Laine, 59037 Lille cedex, France.
Frontotemporal dementia (FTD) diagnostic criteria have been refined, improving sensitivity and reliability for behavioral variant FTD (BvFTD). Early diagnosis remains challenging, especially in late-onset cases, highlighting the need for advanced biomarkers and systematic assessments.
Area of Science:
- Neurology
- Neuroscience
- Geriatrics
Background:
- Frontotemporal dementia (FTD) diagnosis has evolved with refined clinical and pathological criteria.
- The latest international criteria for behavioral variant FTD (BvFTD) enhance sensitivity and reliability.
- Previously excluded symptoms like amnesia and spatial disorientation are now considered, alongside imaging and biomarkers.
Purpose of the Study:
- To review the evolution and current state of diagnostic criteria for frontotemporal dementia.
- To highlight the challenges in early and accurate diagnosis of BvFTD.
- To emphasize the importance of updated criteria and future biomarker development.
Main Methods:
- Review of international consensus criteria for FTD, focusing on the 2011 BvFTD criteria.
- Analysis of clinical features, imaging, and biomarkers in FTD diagnosis.
- Discussion of diagnostic challenges, including early-onset and late-onset cases.
Main Results:
- The 2011 FTDC criteria are the most sensitive and reliable for diagnosing the clinical syndrome of BvFTD.
- Clinical features alone are limited in predicting underlying histopathology, though neurological signs offer clues.
- Early diagnosis of BvFTD is difficult, particularly in late-onset cases where atrophy may be subtle.
Conclusions:
- Systematic application of updated criteria for BvFTD and other neurodegenerative diseases like Alzheimer's disease aids early and accurate diagnosis.
- Further development of biomarkers and systematic assessment of social cognition are crucial for improving FTD diagnosis.
- Post-mortem examination with detailed clinical data is essential for advancing FTD research and understanding.
Related Concept Videos
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Huntington Disease l: Introduction